Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFAVIRENZ vs RELUGOLIX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EFAVIRENZ vs RELUGOLIX: Safety Overview

Metric EFAVIRENZ RELUGOLIX
Total FAERS Reports 7,893 20,660
Deaths Reported 962 958
Death Rate 12.2% 4.6%
Hospitalizations 1,528 1,699
Average Patient Age 40.7 yrs 72.4 yrs
% Female Patients 37.7% 1.4%
FDA Approval Date Apr 27, 2018 Dec 18, 2020
Manufacturer Camber Pharmaceuticals, Inc. Sumitomo Pharma America, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription